ALVOGEN INC. holds $284.8M across 11 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 8 offers. Recompete timing centers on the Sep 28, 2027 PoP end — agencies typically plan 12–18 months ahead.
OSELTAMIVIR PHOSPHATE 75MG, 10 CT BLISTER (ADULT COURSE)
Current PoP ends Sep 28, 2027 (428 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Track recompete timing in SCOUT →ALVOGEN INC. — $284.8M obligated across 11 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. Free — no card required.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open ALVOGEN INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Register free to start exploring SCOUT →